The Innovator Series: Lupita Nyong’o and the Rewriting of Women’s Pain

How Make Fibroids Count Is Advancing Research, Re-engineering Awareness, and Building a New Standard for Uterine Fibroid Care

Innovation does not always arrive as technology.

Sometimes it arrives as truth.

Lupita Nyong’o stood before the public holding 77 pieces of fruit—blueberries, grapes, lemons, oranges, grapefruit, cantaloupe—each representing a uterine fibroid she has carried in her lifetime. Twenty-five surgically removed. More than fifty still growing. One the size of an orange.

The metaphor was precise.

“These aren’t fruits we chose to harvest,” the campaign states. “They’re unwanted growths that can cause debilitating pain, heavy bleeding, infertility, and a profound loss of control over our own bodies.”

This is not symbolism for spectacle.

It is infrastructure for change.

The Innovator Series spotlights individuals who rewrite systems. Lupita Nyong’o is doing exactly that—by transforming a private diagnosis into a structural correction.

The Diagnosis Behind the Applause

In 2014, the year she won an Academy Award, Lupita was privately diagnosed with uterine fibroids at age 31.

Nearly 30 fibroids were discovered after she insisted on further imaging following years of escalating pain and prolonged periods. She was offered two options: invasive surgery or live with the pain. She chose a myomectomy in November 2014.

When she asked how to prevent recurrence, she was told there was nothing she could do. It was only a matter of time.

Ten years later, she is facing twice as many fibroids.

The deeper shock was not the tumors.

It was the absence of answers.

Despite affecting up to 8 out of 10 women, uterine fibroids remain severely under-researched. When something impacts the majority yet lacks clarity, prevention protocols, and robust treatment innovation, that is not coincidence.

It is systemic neglect.

The Scope We Normalized

Uterine fibroids are non-cancerous growths that develop in or around the uterus. They can range from the size of a pea to as large as a melon.

By age 50:

• Approximately 80% of Black women and 70% of white women will develop fibroids.

• Millions of Hispanic, Latina, and Asian women are affected, often with disparities in diagnosis and treatment access.

• More than 15 million women in the United States alone are currently living with fibroids.

Symptoms can include:

• Heavy menstrual bleeding

• Severe clotting

• Chronic pelvic pain

• Anemia

• Frequent urination

• Fertility complications

And yet from puberty onward, women are conditioned to expect pain as part of the female experience.

Cramping is normal.

Clotting is normal.

Bleeding heavily is normal.

Until it becomes unbearable.

When a condition affects the majority and still surprises women at diagnosis, the issue is not awareness alone. It is prioritization.

From Awareness to Infrastructure

Awareness without funding changes nothing.

That is why Lupita partnered with the Foundation for Women’s Health—an organization created to identify and fund the gaping holes in women’s health research across the entire female life cycle.

Rather than duplicating already well-funded research areas, the Foundation strategically targets neglected gaps and ensures that discoveries move beyond academic journals into practical application.

Together, they are raising $200,000 to fund a uterine fibroid research grant focused specifically on accelerating the development of non-invasive and minimally invasive treatment options.

This is not symbolic philanthropy.

It is targeted advancement.

Historically, fibroid treatment options have leaned heavily toward:

• Myomectomy

• Hormonal suppression

• Hysterectomy

Emerging innovations—uterine artery embolization, MRI-guided focused ultrasound, radiofrequency ablation—signal progress. But progress does not scale without research capital.

Research funding follows pressure.

Pressure follows visibility.

And visibility, in this campaign, has been designed with intention.

Reclaiming the Invisible

Make Fibroids Count does not simply request donations.

It invites participation.

Women can:

• Donate directly to the FWH x Lupita Nyong’o Uterine Fibroid Grant

• Post images with fruit representing the invisible burden they carry using #MakeFibroidsCount

• Create their own fundraisers, inviting friends and family to give in their honor

This final invitation shifts the power dynamic.

Women are not positioned as passive patients navigating a flawed system. They are positioned as co-architects of its redesign.

When a woman starts a fundraiser in her own name, she converts diagnosis into collective leverage. When she posts fruit symbolizing her experience, she transforms medical terminology into shared language. When she gives or gathers capital, she accelerates the research pipeline.

The fruit metaphor reclaims invisibility.

The fundraising model redistributes agency.

The partnership builds infrastructure.

That is innovation with intention.

Uterine fibroids affect up to 80% of Black women and nearly 70% of white women by age 50, with Latina, Hispanic, and Asian women also experiencing high prevalence and significant disparities in diagnosis, treatment access, and research representation. Through Make Fibroids Count, Lupita Nyong'o is advocating for increased fibroid research funding and expanded access to minimally invasive treatment options.

Rewriting the Standard of Endurance

The deeper disruption is cultural.

From adolescence forward, women are conditioned to endure.

Pain is expected.

Bleeding is minimized.

Suffering is individualized.

When something affects 8 out of 10 women and is still treated as a private inconvenience, that reflects a structural blind spot.

Lupita Nyong’o is not a physician. She is not a biotech founder. Yet she is advancing uterine fibroid research by leveraging influence as architecture.

She is elevating reproductive health from whispered inconvenience to funded priority.

That is refinement over rebellion.

Evolution over chaos.

And it recalibrates the reader’s posture.

What have we accepted as inevitable that deserves redesign?

Where have we normalized endurance instead of demanding precision?

Innovation does not always invent something new.

Sometimes it refuses to tolerate what has been ignored.

Reflection to Carry Forward:

Endurance is not the highest form of strength.

Redesign is.

FeelWell Magazine exists to support leaders in this deeper work—where mindset, identity, and leadership meet.

---

Quadeera Teart is the author of ManifestHer: Awakening the Power Within to Build Your God-Sized Vision, Publisher of FeelWell Magazine, and Founder of ManifestHer Media. For over 15 years, she has operated at the intersection of branding, media, and intellectual property—architecting highly visible personal and company brands that scale influence and income. As an Influence Builder, Quadeera specializes in organizing ideas, expertise, and lived experience into premium brand assets, signature programs, and authority-driven platforms. Through her Seen. Heard. Profitable.™ Influence-Building Model, she activates power from within and structures it into refined ecosystems that drive visibility, profitability, cultural impact, and legacy.